Vycor Medical (VYCO) Notes Payables (2010 - 2026)

Vycor Medical's (VYCO) quarterly Notes Payables came in at $312920.0 in Q1 2026, up 1.65% year-on-year from $307832.0 in Q1 2025, and down 4.3% on a QoQ basis from $326978.0 in Q4 2025.

Vycor Medical (VYCO) Notes Payables (2010 - 2026) Analysis & Trends

Vycor Medical (VYCO) has 17 years of Notes Payables data on file, last reported at $312920.0 in Q1 2026.

  • On a quarterly basis, Notes Payables rose 1.65% year-over-year to $312920.0 in Q1 2026; TTM through Mar 2026 was $312920.0, a 1.65% increase from a year earlier, with the FY2025 full-year figure at $326978.0, up 0.86% from the prior year.
  • Notes Payables for Q1 2026 stood at $312920.0, down from $326978.0 in the prior quarter.
  • Over the last five years, Notes Payables for VYCO reached as high as $400873.0 in Q1 2022 and fell as low as $303074.0 in Q2 2025.
  • Historically, Notes Payables has averaged $330334.9 across 5 years, with a median of $324711.0 in 2022.
  • Across the five-year window, Notes Payables increased 24.93% in 2022 and decreased 24.31% in 2023, its largest moves.
  • Year by year, Notes Payables stood at $324711.0 in 2022, then climbed by 1.1% to $328267.0 in 2023, then retreated by 1.24% to $324185.0 in 2024, then climbed by 0.86% to $326978.0 in 2025, then decreased by 4.3% to $312920.0 in 2026.
  • Per Business Quant data, the three most recent Notes Payables figures were $312920.0 in Q1 2026, $326978.0 in Q4 2025, and $340939.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn
10 Vycor Medical 2.34 Mn 2.16 Mn 375,153.00

Historic Data

Download Data
DateValue
Mar 31, 2026 312,920.00
Dec 31, 2025 326,978.00
Sep 30, 2025 340,939.00
Jun 30, 2025 303,074.00
Mar 31, 2025 307,832.00
Dec 31, 2024 324,185.00
Sep 30, 2024 337,179.00
Jun 30, 2024 303,409.00
Mar 31, 2024 313,140.00
Dec 31, 2023 328,267.00
Sep 30, 2023 338,786.00
Jun 30, 2023 303,410.00
Mar 31, 2023 311,396.00
Dec 31, 2022 324,711.00
Sep 30, 2022 337,721.00
Jun 30, 2022 400,873.00
Mar 31, 2022 400,873.00
Dec 31, 2021 319,329.00
Sep 30, 2021 320,873.00
Jun 30, 2021 320,873.00